Increased microRNA-221/222 and decreased estrogen receptor α in the cervical portion of the uterosacral ligaments from women with pelvic organ prolapse

International Urogynecology Journal

Volumn 23, Issue 7, 2012, Pages 929-934

  Shi, Zhonghua ^a   Zhang, Ting ^b   Zhang, Lei ^a   Zhao, Jing ^b   Gong, Jian ^b   Zhao, Chun ^a  

^a WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University   (China)

Author keywords

Estrogen receptor ; MicroRNA 221; MicroRNA 222; Pelvic organ prolapse; Uterosacral ligament

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MICRORNA 221; MICRORNA 222;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAMENT; MENOPAUSE; PARITY; PELVIC ORGAN PROLAPSE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; UTEROSACRAL LIGAMENT; WESTERN BLOTTING;

EID: 84865121250     PISSN: 09373462     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-012-1703-5     Document Type: Article

References (24)

1. Reisenauer C, Shiozawa T, Oppitz M et al (2008) The role of smooth muscle in the pathogenesis of pelvic organ prolapse - an immunohistochemical and morphometric analysis of the cervical third of the uterosacral ligament. Int Urogynecol J Pelvic Floor Dysfunct 19:383-389 (Pubitemid 351234030)
2. Dviri M, Leron E, Dreiher J et al (2011) Increased matrix metalloproteinases-1,-9 in the uterosacral ligaments and vaginal tissue from women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 156:113-117
3. Vulic M, Strinic T, Tomic S et al (2011) Difference in expression of collagen type I and matrix metalloproteinase-1 in uterosacral ligaments of women with and without pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 155:225-228
4. Goh JT (2003) Biomechanical and biochemical assessments for pelvic organ prolapse. Curr Opin Obstet Gynecol 15:391-394 (Pubitemid 37330383)
5. Suzme R, Yalcin O, Gurdol F et al (2007) Connective tissue alterations in women with pelvic organ prolapse and urinary incontinence. Acta Obstet Gynecol Scand 86:882-888 (Pubitemid 47035821)
6. Moalli PA, Shand SH, Zyczynski HM et al (2005) Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol 106:953-963 (Pubitemid 41532900)
7. Connell KA, Guess MK, Chen H et al (2008) HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse. J Clin Invest 118:1050-1055 (Pubitemid 351364612)
8. Mokrzycki M, Mittal K, Smilen S et al (1997) Estrogen and progesterone receptors in the uterosacral ligament. Obstet Gynecol 90:402-404 (Pubitemid 27357932)
9. Hall JM, McDonnell DP (2005) Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. Mol Interv 5:343-357 (Pubitemid 43060715)
10. Smith P, Heimer G, Norgren A et al (1990) Steroid hormone receptors in pelvic muscles and ligaments in women. Gynecol Obstet Invest 30:27-30 (Pubitemid 20248166)
11. Ewies AA, Thompson J, Al-Azzawi F (2004) Changes in gonadal steroid receptors in the cardinal ligaments of prolapsed uteri: immunohistomorphometric data. Hum Reprod 19:1622-1628 (Pubitemid 38997193)
12. Lang JH, Zhu L, Sun ZJ et al (2003) Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse. Int J Gynaecol Obstet 80:35-39 (Pubitemid 36071339)
13. Bai SW, Chung DJ, Yoon MJ et al (2005) Roles of estrogen receptor, progesterone receptor, p53 and p21 in pathogenesis of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 16:492-496 (Pubitemid 41631065)
14. Reinhart BJ, Slack FJ, Basson M et al (2000) The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901-906 (Pubitemid 30130993)
15. Zhao JJ, Lin JH, Yang H et al (2008) MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283:31079-31086
16. Zhao C, Dong J, Jiang T et al (2011) Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS One 6:e23925
17. Wahab M, Thompson J, Hamid B et al (1999) Endometrial histomorphometry of trimegestone-based sequential hormone replacement therapy: a weighted comparison with the endometrium of the natural cycle. Hum Reprod 14:2609-2618 (Pubitemid 29473938)
18. Chen HY, Chung YW, Lin WY et al (2008) Estrogen receptor alpha polymorphism is associated with pelvic organ prolapse risk. Int Urogynecol J Pelvic Floor Dysfunct 19:1159-1163
19. Di Leva G, Gasparini P, Piovan C et al (2010) MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst 102:706-721
20. Cochrane DR, Cittelly DM, Howe EN, et al (2010) MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer. Horm Cancer 1:306-319
21. Zhang N, Moran MS, Huo Q et al (2011) The hormonal receptor status in breast cancer can be altered by neoadjuvant chemotherapy: a meta-analysis. Cancer Invest 29:594-598
22. Ismail SI, Bain C, Hagen S (2010) Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women. Cochrane Database Syst Rev 9:CD007063
23. Rao X, Di Leva G, Li M et al (2011) MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 30:1082-1097
24. Terasawa K, Ichimura A, Sato F et al (2009) Sustained activation of ERK1/2 by NGF induces microRNA-221 and 222 in PC12 cells. FEBS J 276:3269-3276